The assessment of pharmaceutical care of patients with cardiovascular diseases by the results of frequency analysis of drug prescribing

Abstract

Aim. To assess the state of pharmaceutical care of patients with cardiovascular diseases (CVD) based on the results of frequency analysis. Materials and methods. In the course of the study the cards of patients with CVD, who were on the outpatient treatment at the Kharkiv City Clinical Hospital No. 27, were used. The following methods were used: frequency analysis of drug prescriptions, statistical analysis and generalization of information. Results. During the frequency analysis it was found that within the framework of the “Available medicines” program the drug Enalapril, 20 mg, No. 20, was the leader among drug prescriptions – 526 (6.70 %), and Magnikor, 75 mg, No. 100 – 870 (11.08 %) was the first among drugs that were not included in the list of this program. Calculation of the intensity of prescriptions (Кі) of drugs and their ranking into three groups showed that the drug Magnikor – Acetylsalicylic Acid (B01AC06, antiaggregants) was referred to the III group with a high Кі = 0.731. Conclusions. Due to the high rate of prescribing drugs of the acetylsalicylic acid group, which has the proven effectiveness in preventing development of cardiovascular complications, such as myocardial infarctions and strokes, it becomes relevant to include this acid in the list of drugs to be reimbursed within the framework of the “Available medicines” program. Inclusion of acetylsalicylic acid, in particular the drug Magnikor, is a promising step in the expansion of the program and improvement of pharmaceutical care for patients with CVD.

Authors and Affiliations

A. S. Nemchenko, V. M. Nazarkina, Yu. Ye. Kurylenko

Keywords

Related Articles

The marketing analysis of antibacterial drugs of the azitrimicine group for use in pediatrics

Aim. To assess the state of the Ukrainian pharmaceutical market for azithromycin drugs used to treat infection diseases in children, including pertussis. Materials and methods. The marketing analysis of azithromycin drug...

Дослідження ринку лікарських препаратів, які застосовуються для місцевого лікування дерматитів

Метою роботи є аналіз ринку лікарських препаратів (ЛП), які представлені на фармацевтичному ринку України та застосовуються для місцевої терапії дерматитів, за фармакотерапевтичними групами, складом, формами випуску та к...

Аналіз сучасних підходів до попередження антимікробної резистентності: роль і місце фізико-хімічних методів досліджень in vitro та оцінки біоеквівалентності

Проблема антимікробної резистентності є одним з ключових викликів у сучасному світі. Глобальний аналіз ситуації з розвитком резистентності щодо антибактеріальних лікарських засобів показав, що вирішення цього завдання по...

The “Medicrime Convention” as an anti-crime instrument in the field of the counterfeiting of medical products in Ukraine

Aim. To study the compliance of the measures provided for by the “Medicrime Convention” with the organizational and legal measures used in Ukraine in order to increase the effectiveness of countering counterfeiting of me...

The study of the individual competencies of a modern leader in the pharmaceutical sector of healthcare

Aim. To study the individual competencies of a modern leader as the coordinator of the organizational system in the pharmaceutical sector of healthcare in the context of adaptive management of the organizational culture....

Download PDF file
  • EP ID EP670483
  • DOI 10.24959/sphhcj.18.120
  • Views 147
  • Downloads 0

How To Cite

A. S. Nemchenko, V. M. Nazarkina, Yu. Ye. Kurylenko (2018). The assessment of pharmaceutical care of patients with cardiovascular diseases by the results of frequency analysis of drug prescribing. Соціальна фармація в охороні здоров’я, 4(3), 20-26. https://europub.co.uk/articles/-A-670483